Raw data supporting Jaaks and Coker et al., 2022
(10.1038/s41586-022-04437-2). Raw data from initial drug combination
screen using cancer cell lines. Cell line viability assay measured by
fluorescence intensity.
Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.